Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
11/12/2019
/
Publications
/
Hypofractionation
Survival
This study by MGH retrospectively analyzed 66 patients with unresectable intrahepatic cholangiocarcinoma (ICC) who were treated with hypofractionated proton (32...
Proton beam therapy for liver cancers.
03/02/2020
/
Publications
/
Dosimetry
Toxicity
A review article examined the latest utilization of PBT for hepatocellular carcinoma and cholangiocarcinoma, as well as liver metastasis. The dosimetric...
Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma.
03/03/2020
/
Publications
/
Survival
A study by the Samsung group from Korea published in the Green Journal. A total of 103 patients treated with proton therapy including 70 in the PS group and 33...
Clinical results of active scanning proton therapy for primary liver tumors.
10/07/2020
/
Publications
/
This study reported clinical outcomes of 18 patients including 14 patients with hepatocellular carcinoma (HCC) and 3 patients with intrahepatic...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.